What is OCCI?
OCCI, Inc. operates as a premier network of research centers, distinguishing itself through a rigorous focus on Psychiatry, Neurology, and General Medicine. By maintaining a locally-owned operational model while achieving national recognition, the company bridges the gap between pharmaceutical innovation and patient-centric research. Their expertise in managing late-stage clinical trials has positioned them as a preferred partner for global biotechnology firms seeking reliable, high-quality data collection and patient recruitment services. The firm's ability to navigate the complexities of phase II-IV studies underscores its technical proficiency and commitment to advancing medical science.
How much funding has OCCI raised?
OCCI has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in OCCI
PPP
Public-Private Partnership
What's next for OCCI?
With the infusion of this latest capital, OCCI is well-positioned to scale its infrastructure and enhance its technological capabilities in trial management. The strategic allocation of these funds will likely focus on broadening the scope of their therapeutic research areas and increasing the throughput of their clinical trial sites. As the company transitions through this late-stage growth phase, the focus will remain on maintaining the high standards of data integrity that have earned them their reputation among top-tier pharmaceutical developers. Future growth will likely involve deeper integration with digital health platforms to streamline patient assessments and improve the efficiency of trial enrollment processes.
See full OCCI company page
